Everyday rush and stress leave little time for proper rest. This takes a toll on the body, and emotional health often suffers first. Audiovisual relaxation helps cope with daily strain and improve mood. Coordinated acoustic and visual signals act on hearing and vision, and can ease symptoms of depression, anxiety and insomnia. Wellbeing, mood and concentration often improve; with electrotherapy, heart rate may slow and blood pressure tend to normalise.
Treatment of depression, anxiety and insomnia with electrotherapy
Audiovisual relaxation can be combined with cranial electrotherapy stimulation. The method is suitable for women and men, and can be used in adolescents and older adults. The benefit can be lasting. It is an unconventional but effective way to address insomnia, depressive symptoms and anxiety.
The procedure uses ALPHA-STIM®, a clinically tested medical device that reduces anxiety, insomnia and depression with cranial electrotherapy stimulation (CES).
It generates a patented waveform that other devices cannot reproduce. A microcurrent is delivered through small clips on the earlobes to stimulate and modulate specific groups of nerve cells in the brain.
Alpha-Stim® is scientifically shown to be a safe and effective electrotherapy device for insomnia, anxiety and depression. It does not cause dependence and has no typical side effects.
Low mood, poor sleep and flattened emotions are common in depression. Triggers may include major life events, daily stress, burnout or exhaustion. Early help matters, because long-standing depression is harder to treat. Audiovisual relaxation with electrotherapy can ease low mood, insomnia and depression. It is especially useful when:
- insomnia makes it hard to fall or stay asleep — Alpha-Stim® can support longer, calmer sleep;
- anxiety affects many areas of life — Alpha-Stim® can provide rapid and lasting relief of anxiety and stress;
- depression takes away interest in things that once brought pleasure — Alpha-Stim® is a non-drug option for depressive symptoms.
What can you expect?
Current approaches often act on several symptoms at once and do not disrupt the natural cycle of behaviour and emotion.
Anxiety often eases within a single session; the effect may last hours or days. Other methods can take more time and effort. Audiovisual relaxation is a gentle option to include in care.
Insomnia often improves after the first treatments, but a clear change may take up to 4 weeks.
Depression treatment usually lasts at least 3 weeks with daily sessions. When symptoms improve, Alpha-Stim® is used 2–3 times a week or less to maintain the result.
Duration and course
Depression, anxiety and insomnia are treated differently. The specialist selects the cycle according to symptoms. One session lasts about 30 minutes and is comfortable: you simply relax. Stimulation of vision and hearing often makes heavy emotions recede. Sometimes one or a few sessions are enough; in more complex cases treatment continues longer.
Price
The cost is modest compared with the benefit — less anxiety, better sleep and milder depressive symptoms. A prepaid course usually lowers the price per session.
Sessions also work as prevention: they relax, lift mood and help manage stress and burnout before problems become severe.
Recommended course
There is no single course for everyone. Depression may need a longer, more frequent programme. Insomnia and anxiety are assessed individually, according to severity. It also helps to understand why the symptoms appeared. When they are linked to stress, audiovisual relaxation with electrotherapy is a suitable option.
What makes Alpha-Stim® different?
Audiovisual relaxation is combined with medical electrotherapy using ALPHA-STIM®. Benefits include:
- it helps regulate brain function in anxiety, insomnia and depression;
- the session is pleasant and painless;
- treatment is short and the effect can last;
- no dependence;
- no typical side-effect risk;
- overdose is not possible;
- no physical restrictions during the session.
Alpha-Stim® AID is a certified Class IIa, Type B medical device (EU Directive 93/42/EEC). It can be combined with other treatments.